Alison Kay Holzer is a prominent inventor based in Redwood City, CA, known for her significant contributions to the field of biotechnology. With a total of seven patents to her name, she has made remarkable advancements in therapeutic methods and diagnostic tools.

Latest Patents

Among her latest patents are the LOX and LOXL2 inhibitors and their uses. This application relates to anti-LOX and anti-LOXL2 antibodies, which are utilized in purification, diagnostic, and therapeutic methods. The antibodies include monoclonal antibodies, humanized antibodies, and functional fragments. These innovative antibodies can identify and treat various conditions, such as fibrotic conditions and angiogenesis, and can prevent the transition from an epithelial cell state to a mesenchymal cell state. Additionally, she has developed chemotherapeutic methods and compositions that enhance the cell-killing activity of anti-neoplastic agents by inhibiting lysyl oxidase-type enzyme activity. These methods also include screening for chemotherapeutic agents and molecules that enhance their activity using cells grown on an extracellular matrix.

Career Highlights

Alison is currently associated with Gilead Biologics, Inc., where she continues to push the boundaries of scientific research and innovation. Her work has been instrumental in developing new therapeutic strategies that have the potential to improve patient outcomes.

Collaborations

Alison collaborates with talented professionals in her field, including her coworkers Victoria Smith and Scott Ogg. Their combined expertise fosters a dynamic environment for innovation and discovery.

Conclusion

Alison Kay Holzer's contributions to biotechnology through her patents and collaborative efforts exemplify her commitment to advancing medical science. Her work continues to pave the way for new therapeutic approaches that can significantly impact healthcare.

This text is generated by artificial intelligence and may not be accurate.